Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity

Critical Care

Volumn 10, Issue 6, 2006, Pages

  Heying, Ruth ^a   van Oeveren, Wim ^b   Wilhelm, Stefanie ^a   Schumacher, Katharina ^a   Grabitz, Ralph G ^a   Messmer, Bruno J ^a   Seghaye, Marie Christine ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTITHROMBIN; CEFOTIAM; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; FRESH FROZEN PLASMA; FUROSEMIDE; HEPARIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROPRUSSIDE SODIUM; PROTHROMBIN; THROMBOXANE B2; TISSUE FACTOR PATHWAY INHIBITOR; ANTITHROMBIN III;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HUMAN; HUMAN CELL; INFANT; INTERMETHOD COMPARISON; LUNG ATRESIA; MALE; PALLIATIVE THERAPY; PEDIATRIC SURGERY; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN FUNCTION; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TRICUSPID VALVE ATRESIA; BLOOD CLOTTING; BLOOD CLOTTING TEST; EXTRACORPOREAL CIRCULATION; HEART DEFECTS, CONGENITAL; PATHOPHYSIOLOGY; PRESCHOOL CHILD; THROMBOSIS;

ANTITHROMBIN III; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; HEART BYPASS, RIGHT; HEART DEFECTS, CONGENITAL; HUMANS; PROSPECTIVE STUDIES; THROMBOSIS;

EID: 34447645672     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5108     Document Type: Article

References (42)

1. Chan AK Leaker M Burrows FA Williams WG Gruenwald CE Whyte L Adams M Brooker LA Adams H Mitchell L Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass Thromb Haemost 1997 77 270-277 9157580
2. Despotis GJ Joist JH Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: An update J Cardiothorac Vasc Anesth 1999 13 4 Suppl 1 18-29 discussion 36-37 10468245
3. Jaggers JJ Neal MC Smith PK Ungerleider RM Lawson JH Infant cardiopulmonary bypass: A procoagulant state Ann Thorac Surg 1999 68 513-520 10.1016/S0003-4975(99)00644-X 10475421
4. Ries M Klinge J Rauch R Age-related reference values for activation markers of the coagulation and fibrinolytic systems in children Thromb Res 1997 85 341-344 10.1016/S0049-3848(97)00019-4 9062957
5. Mangano DT Multicenter Study of Perioperative Ischemia Research Group Aspirin and mortality from coronary bypass surgery N Engl J Med 2002 347 1309-1317 10.1056/NEJMoa020798 12397188
6. Pearl JM Manning PB McNamara JL Saucier MM Thomas DW Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass Ann Thorac Surg 1999 68 1369-1375 10.1016/S0003-4975(99)00978-9 10543508
7. Kojima T Gando S Kemmotsu O Mashio H Goda Y Kawahigashi H Watanabe N Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: Role of tissue factor pathway inhibitor J Cardiothorac Vasc Anesth 2001 15 60-64 10.1053/jcan.2001.20278 11254842
8. Adams MJ Cardigan RA Marchant WA Grocott MP Mythen MG Mutch M Purdy G Mackie IJ Machin SJ Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass J Cardiothorac Vasc Anesth 2002 16 59-63 10.1053/jcan.2002.29677 11854880
9. Kawahito K Kawakami M Fujiwara T Adachi H Ino T Interleukin-8 and monocyte chemotactic activating factor responses to cardiopulmonary bypass J Thorac Cardiovasc Surg 1995 110 99-102 10.1016/ S0022-5223(05)80014-5 7609574
10. Cromme-Dijkhuis AH Hess J Hahlen K Henkens CM Bink-Boelkens MT Eygelaar AA Bos E Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders J Thorac Cardiovasc Surg 1993 106 1126-1132 8246550
11. Masuda M Kado H Shiokawa Y Fukae K Suzuki M Murakami E Yasui H Clinical results of the staged Fontan procedure in high-risk patients Ann Thorac Surg 1998 65 1721-1725 10.1016/S0003-4975(98)00264-1 9647088
12. Day RW Boyer RS Tait VF Ruttenberg HD Factors associated with stroke following the Fontan procedure Pediatr Cardiol 1995 16 270-275 10.1007/ BF00798060 8650012
13. Jahangiri M Kreutzer J Zurakowski D Bacha E Jonas RA Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation J Thorac Cardiovasc Surg 2000 120 778-782 10.1067/ mtc.2000.108903 11003762
14. Kaulitz R Luhmer I Bergmann F Rodeck B Hausdorf G Sequelae after modified Fontan operation: Postoperative haemodynamic data and organ function Heart 1997 78 154-159 9326989
15. Ravn HB Hjortdal VE Stenbog EV Emmertsen K Kromann O Pedersen J Sorensen KE Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection Heart 2001 85 61-65 10.1136/ heart.85.1.61 11119465
16. Odegard KC McGowan FX Jr Zurakowski D DiNardo JA Castro RA del Nido PJ Laussen PC Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure Ann Thorac Surg 2002 73 1770-1777 10.1016/S0003-4975(02)03580-4 12078768
17. Boisclair MD Lane DA Philippou H Sheikh S Hunt B Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2 Thromb Haemost 1993 70 253-258 8236130
18. Knudsen L Hasenkam JM Kure HH Hughes P Bellaiche L Ahlburg P Djurhuus C Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery Thromb Res 1996 84 45-54 10.1016/ 0049-3848(96)00160-0 8885146
19. Burman JF Chung HI Lane DA Philippou H Adami A Lincoln JC Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass Lancet 1994 344 1192-1193 10.1016/S0140-6736(94)90509-6 7934541
20. Boldt J Knothe C Welters I Dapper FL Hempelmann G Normothermic versus hypothermic cardiopulmonary bypass: Do changes in coagulation differ? Ann Thorac Surg 1996 62 130-135 10.1016/0003-4975(96)00239-1 8678631
21. Paparella D Brister SJ Buchanan MR Coagulation disorders of cardiopulmonary bypass: A review Intensive Care Med 2004 30 1873-1881 10.1007/s00134-004-2388-0 15278267
22. Owings JT Pollock ME Gosselin RC Ireland K Jahr JS Larkin EC Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques Arch Surg 2000 135 1042-1047 10.1001/archsurg.135.9.1042 10982508
23. Adatia I Barrow SE Stratton PD Miall-Allen VM Ritter JM Haworth SG Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease Circulation 1993 88 5 Pt 1 2117-2122 8222105
24. Adatia I Barrow SE Stratton P Ritter JM Haworth SG Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease Br Heart J 1993 69 179-182 8435245
25. Ansley DM Qayumi AK Duncan S Merrick PM Klein R Platelet activating factor and thromboxane B2 production after cardiopulmonary bypass J Invest Surg 1997 10 87-95 9219083
26. Ernofsson M Thelin S Siegbahn A Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: A clinical study J Thorac Cardiovasc Surg 1997 113 576-584 10.1016/ S0022-5223(97)70373-8 9081105
27. Khan MM Gikakis N Miyamoto S Rao AK Cooper SL Edmunds LH Jr Colman RW Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass Ann Thorac Surg 1999 68 473-478 10.1016/ S0003-4975(99)00551-2 10475415
28. Gessler P Pretre R Burki C Rousson V Frey B Nadal D Monocyte function-associated antigen expression during and after pediatric cardiac surgery J Thorac Cardiovasc Surg 2005 130 54-60 10.1016/ j.jtcvs.2005.01.008 15999041
29. Weyrich AS Denis MM Kuhlmann-Eyre JR Spencer ED Dixon DA Marathe GK McIntyre TM Zimmerman GA Prescott SM Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates Circulation 2005 111 633-642 10.1161/01.CIR.0000154607.90506.45 15668340
30. Schecter AD Rollins BJ Zhang YJ Charo IF Fallon JT Rossikhina M Giesen PL Nemerson Y Taubman MB Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells J Biol Chem 1997 272 28568-28573 10.1074/jbc.272.45.28568 9353321
31. Garlichs CD Kozina S Fateh-Moghadam S Handschu R Tomandl B Stumpf C Eskafi S Raaz D Schmeisser A Yilmaz A Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia Stroke 2003 34 1412-1418 10.1161/01.STR.0000074032.64049.47 12764232
32. Gessler P Pretre R Hohl V Rousson V Fischer J Dahinden C CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery Shock 2004 22 513-520 10.1097/ 01.shk.0000145939.54838.51 15545821
33. Szaba FM Smiley ST Roles for thrombin and fibrin(ogen) in cytokine/ chemokine production and macrophage adhesion in vivo Blood 2002 99 1053-1059 10.1182/blood.V99.3.1053 11807012
34. Qing M Schumacher K Heise R Woltje M Vazquez-Jimenez JF Richter T Arranda-Carrero M Hess J von Bernuth G Seghaye MC Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects J Am Coll Cardiol 2003 41 2266-2274 10.1016/ S0735-1097(03)00477-7 12821258
35. Levy JH Tanaka KA Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 2003 75 S715-720 10.1016/S0003-4975(02)04701-X 12607717
36. Hovels-Gurich HH Vazquez-Jimenez JF Silvestri A Schumacher K Minkenberg R Duchateau J Messmer BJ von Bernuth G Seghaye MC Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries J Thorac Cardiovasc Surg 2002 124 811-820 10.1067/mtc.2002.122308 12324741
37. Cromme-Dijkhuis AH Henkens CM Bijleveld CM Hillege HL Bom VJ van der Meer J Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations Lancet 1990 336 1087-1090 10.1016/ 0140-6736(90)92568-3 1977979
38. Jahangiri M Shore D Kakkar V Lincoln C Shinebourne E Coagulation factor abnormalities after the Fontan procedure and its modifications J Thorac Cardiovasc Surg 1997 113 989-992 discussion 992-993 10.1016/ S0022-5223(97)70283-6 9202678
39. van Nieuwenhuizen RC Peters M Lubbers LJ Trip MD Tijssen JG Mulder BJ Abnormalities in liver function and coagulation profile following the Fontan procedure Heart 1999 82 40-46 10377307
40. Ranucci M Frigiola A Menicanti L Ditta A Boncilli A Brozzi S Postoperative antithrombin levels and outcome in cardiac operations Crit Care Med 2005 33 355-360 10.1097/01.CCM.0000153409.55645.58 15699839
41. Hashimoto K Yamagishi M Sasaki T Nakano M Kurosawa H Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation Ann Thorac Surg 1994 58 799-804 discussion 804-805 7944706
42. Wiedermann CJ Clinical review: Molecular mechanisms underlying the role of antithrombin in sepsis Crit Care 2006 10 209 1550851 16542481 10.1186/ cc4822